Tri-county stocks mixed as stimulus package stalls
A 3 percent drop in U.S. equities markets hit smaller stocks in the Tri-Counties on March 23, as a stimulus package to combat the economic fallout of the coronavirus failed for a second time to gain legislative approval. The region’s companies had mixed results, with gains for eight out of the 10 largest firms. Goleta Read More →
CLU economists predict downturn worse than Great Recession
California Lutheran University’s economic forecast group is warning that policymakers have limited options to head off a downturn that could be worse than the Great Recession. In an update to recent forecasts, the Center for Economic Research & Forecasting warns that massive stimulus efforts may not help speed a recovery if “countless numbers of small Read More →

T.O. industrial building sold for biotech lab redevelopment
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Tri-county stocks end week with mixed results
Tri-county public companies ended the worst week for Wall Street since 2008 with a 5 percent drop March 20, as the threat of a recession loomed larger in the wake of the coronavirus outbreak. Stocks had a mixed close, with losses among several biotech firms, including regional biotech giant Amgen. Shares fell another 5.3 percent Read More →

Plains oil spill settlement to fund Gaviota restoration
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
MannKind adapting technology for coronavirus
Westlake Village-based MannKind became the latest company to turn its efforts toward treating the COVID-19 pandemic, with the announcement of a collaboration with a Los Angeles firm that aims to adapt its inhalable drug delivery technology to combat the respiratory infection. The company best known for its inhalable insulin product Afrezza said it would reorient Read More →







